Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
2,531 people get SYK articles and Market Currents by email alert.
Get email alerts on SYK »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
Stryker Increases Dividends, Expands In ChinaPeter Geschek • Wed, Jan 30 -
-
-
-
-
-
-
-
-
-
-
Earnings Preview: Stryker CorporationVytautas Drumelis • Tue, Jul 17, 2012 -
-
Stryker's Business Healthier Than The StockStephen Simpson • Wed, Apr 18, 2012
-
-
-
-
Stryker Corporation - Shareholder/Analyst CallTue, Apr 30
-
Stryker Management Discusses Q3 2012 Results - Earnings Call TranscriptWed, Oct 17, 2012
-
Stryker Corporation - Shareholder/Analyst CallThu, Sep 6, 2012
-
Stryker Management Discusses Q2 2012 Results - Earnings Call TranscriptWed, Jul 18, 2012
-
Stryker's CEO Discusses Q1 2012 Results - Earnings Call TranscriptTue, Apr 17, 2012
-
Stryker's CEO Discusses Q4 2011 Results - Earnings Call TranscriptTue, Jan 24, 2012
-
Stryker's CEO Discusses Q3 2011 Results - Earnings Call TranscriptThu, Oct 20, 2011
-
Stryker's CEO Discusses Q2 2011 Results - Earnings Call TranscriptTue, Jul 19, 2011 • 1 Comment
-
Stryker's CEO Discusses Q1 2011 Results - Earnings Call TranscriptTue, Apr 19, 2011
-
Stryker's CEO Discusses Q4 2010 Results - Earnings Call TranscriptTue, Jan 25, 2011
-
Stryker Corporation Q2 2010 Earnings Call TranscriptTue, Jul 20, 2010
-
Stryker Corporation Q1 2010 Earnings Call TranscriptTue, Apr 20, 2010
-
Stryker Corporation Q4 2009 Earnings Call TranscriptWed, Jan 27, 2010
-
Stryker Corporation Q3 2009 Earnings Call TranscriptWed, Oct 21, 2009
-
Stryker Corp. Q2 2009 Earnings Call TranscriptTue, Jul 21, 2009
-
at CNBC.com (Apr 24, 2013)
-
at CNBC.com (Apr 23, 2013)
-
at CNBC.com (Apr 20, 2013)
-
at CNBC.com (Feb 12, 2013)
-
at CNBC.com (Jan 24, 2013)
-
at CNBC.com (Jan 23, 2013)
-
at CNBC.com (Jan 23, 2013)
-
at CNBC.com (Jan 23, 2013)
-
at MarketWatch.com (Jan 23, 2013)
-
at CNBC.com (Jan 23, 2013)
-
at CNBC.com (Jan 22, 2013)
-
at CNBC.com (Jan 18, 2013)
-
at CNBC.com (Jan 7, 2013)
-
at CNBC.com (Dec 7, 2012)
-
at CNBC.com (Dec 5, 2012)
-
at CNBC.com (Nov 15, 2012)
-
at MarketWatch.com (Oct 17, 2012)
-
at CNBC.com (Oct 17, 2012)
-
at CNBC.com (Sep 24, 2012)
-
at CNBC.com (Sep 5, 2012)
SYK vs. ETF Alternatives
Company Description
Stryker Corporation (the Company or Stryker) is one of the world’s leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, April 17, 2012, 8:05 PM More on Stryker (SYK): Q1 earnings came in largely in line with Street estimates on a slight Y/Y increase in revenue. Net earnings rose 14% as the medical-device maker saw sales of its hip and knee replacements increase, an encouraging sign that the orthopedic market may be picking up. Shares +1.4% AH. Comment! [Healthcare, Earnings]
- Tuesday, April 17, 2012, 4:03 PM Stryker (SYK): Q1 EPS of $0.99 in-line. Revenue of $2.16B (+7% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
- Tuesday, April 17, 2012, 12:10 AM Notable earnings after Tuesday's close: CREE, CSX, EWBC, FULT, IBM, INTC, LLTC, STX, SYK, URI, YHOO 1 Comment [Earnings]
- Monday, April 16, 2012, 5:35 PM Notable earnings after Tuesday's close: CREE, CSX, EWBC, FULT, IBM, INTC, LLTC, STX, SYK, URI, YHOO Comment! [Earnings]
- Wednesday, March 21, 2012, 8:42 AM The FDA finds that a heart stent developed by Stryker (SYK) might not be worth the additional risks for patients because it offers no added benefits over existing drugs used to help prevent strokes. (report) 2 Comments [Healthcare]
- Tuesday, February 14, 2012, 12:59 PM Stryker (SYK -0.7%) dips after being downgraded to Neutral on valuation at Lazard, citing the lack of a new product cycle and the resignation of its CEO. Comment! [Healthcare, On the Move]
- Thursday, February 9, 2012, 5:57 AM Stryker (SYK) CEO Stephen MacMillan has resigned due to family reasons, the firm said yesterday, adding that CFO Curt Hartman will take over on an interim bais until a successor is found. MacMillan's exit "is not good news," says Collins Stewart's Tao Levy. "He’s navigated the company well during some very difficult market times." Comment! [Top Stories]
- Friday, February 3, 2012, 7:51 AM A new government report shines a bright spotlight on the pricing of high-priced medical devices with cost variance ranging as much as 50% across different hospitals for the purchases of the same products. The GAO report raises "serious concerns" over the prices hospitals and Medicare pay for medical devices, as well as stoking up Congressional backlash on the issue. Companies that could be impacted by pricing reform include MDT, BAX, COV, SYK, TMO, ISRG, BDX, STJ, EW, BSX, BCR, VAR. 1 Comment [Healthcare, Quick Ideas]
- Tuesday, January 24, 2012, 4:14 PM More on Stryker (SYK): The company reaffirms 2012 guidance, anticipating a constant currency sales increase of 3.5-6.5% and EPS growth at "double-digit levels" over 2011. The company repurchased $83M of shares in Q4, bringing the year's total to $622M. Shares +0.5% AH. Comment! [Healthcare, Earnings]
- Tuesday, January 24, 2012, 4:05 PM Stryker (SYK): Q4 EPS of $1.02 misses by $0.01. Revenue of $2.2B (+11% Y/Y) misses by $20M. Shares -0.1% AH. (PR) Comment! [Earnings, Healthcare]
- Tuesday, January 24, 2012, 12:10 AM Notable earnings after Tuesday's close: AAPL, ALTR, AMD, CA, FIO, NSC, RFMD, STLD, SYK, TPX, TSS, YHOO Comment! [Earnings]
- Monday, January 23, 2012, 5:35 PM Notable earnings after Tuesday's close: AAPL, ALTR, AMD, CA, FIO, NSC, RFMD, STLD, SYK, TPX, TSS, YHOO Comment! [Earnings]
- Wednesday, January 18, 2012, 2:03 PM Stryker Biotech, a Stryker Corp. (SYK -0.9%) unit, pleaded guilty to misbranding a medical device during its trial over charges it marketed an unapproved mixture of products for strengthening human bone growth. The guilty plea means Stryker Corp. CEO Stephen MacMillan won't have to testify. Stryker will also pay a $15M fine. (submitted by Holly Thompson) Comment! [Healthcare]
- Tuesday, January 10, 2012, 4:38 PM Medical equipment maker Stryker (SYK) drops 1.1% AH after preannouncing Q4 revenue of $2.2B (+11% Y/Y) and 2011 EPS of $1.02-$1.04, largely in-line with a consensus of $2.23B and $1.03. The company is also guiding for double-digit 2012 EPS growth; the current consensus is for a 10% increase. Comment! [Healthcare, Earnings]
- Thursday, December 29, 2011, 9:28 AM Medical device maker Synthes accuses Stryker (SYK) in a lawsuit of raiding its San Francisco sales force and using confidential information from former employees. Stryker seeks to obtain "an improper competitive advantage” in the industry for medical implants and instruments used in spinal surgery, Synthes says in a complaint filed today. Comment! [Healthcare]
- Thursday, December 15, 2011, 11:07 AM Stryker (SYK -0.1%) drifts lower after being downgraded to Neutral at Goldman Sachs, citing diminishing growth potential and weak end markets. Comment!
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Robert Freedland
Aging population will increase demand for orthopedic devices by Stryker (SYK) and Zimmer (ZMH). - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Alex B. Gray
Stryker $SYK reported quarter ended 9/30/10 sales increased 7% to $1.768B and net earnings increased 47.5% to $338M. - View all 0 replies
-
- View all 0 replies
LATEST REPLIES